Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 29, 2008
Behavioral effects of dietary cholesterol in rats tested in experimental models of mild stress and cognition tasksVincenzo Micale, Giovanni Scapagnini, Claudia Colombrita, et al.
Frontiers in Psychiatry|July 29, 2015
Sex Differences in the Reinstatement of Methamphetamine Seeking after Forced Abstinence in Sprague-Dawley RatsJana Ruda-Kucerova, Petra Amchova, Zuzana Babinska, et al.
Frontiers in Pharmacology|April 6, 2019
The Cannabinoid CB1 Antagonist TM38837 With Limited Penetrance to the Brain Shows Reduced Fear-Promoting Effects in MiceVincenzo Micale, Filippo Drago, Pia K Noerregaard, et al.
Pharmacology, Biochemistry, and Behavior|May 23, 2008
Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditionsVincenzo Micale, Alessandra Tamburella, Gian Marco Leggio, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 15, 2010
Dopamine D3 receptor knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepamGian Marco Leggio, Vincenzo Micale, Bernard Le Foll, et al.
CNS Neuroscience & Therapeutics|February 29, 2024
Olanzapine, but not haloperidol, exerts pronounced acute metabolic effects in the methylazoxymethanol rat modelKaterina Horska, Silje Skrede, Jan Kucera, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 26, 2008
Signaling through cGMP-dependent protein kinase I in the amygdala is critical for auditory-cued fear memory and long-term potentiationCindy Paul, Florian Schöberl, Pascal Weinmeister, et al.
European Journal of Pharmacology|July 23, 2013
Dopamine D(3) receptor as a new pharmacological target for the treatment of depressionGian Marco Leggio, Salvatore Salomone, Claudio Bucolo, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|May 26, 2016
Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female ratsJana Ruda-Kucerova, Zuzana Babinska, Petra Amchova, et al.
Pharmacology & Therapeutics|September 14, 2022
Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targetsVincenzo Micale, Martina Di Bartolomeo, Serena Di Martino, et al.
Pageof 7